EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
Overview | Financials
Company Name | EyePoint Pharmaceuticals, Inc. |
Symbol | EYPT |
Currency | USD |
Price | 7.33 |
Market Cap | 500,279,830 |
Dividend Yield | 0% |
52-week-range | 6.9 - 30.99 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jay S. Duker M.D. |
Website | https://eyepointpharma.com |
An error occurred while fetching data.
About EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD